Kenvue Inc. $KVUE Shares Acquired by Oak Family Advisors LLC

Oak Family Advisors LLC grew its holdings in Kenvue Inc. (NYSE:KVUE) by 35.4% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 471,239 shares of the company’s stock after acquiring an additional 123,214 shares during the quarter. Kenvue comprises 2.3% of Oak Family Advisors LLC’s investment portfolio, making the stock its 12th biggest holding. Oak Family Advisors LLC’s holdings in Kenvue were worth $8,124,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Physician Wealth Advisors Inc. boosted its holdings in Kenvue by 67.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after purchasing an additional 618 shares in the last quarter. Elyxium Wealth LLC purchased a new position in Kenvue in the fourth quarter valued at approximately $26,000. MV Capital Management Inc. acquired a new stake in Kenvue during the fourth quarter worth approximately $28,000. Reflection Asset Management acquired a new stake in Kenvue during the fourth quarter worth approximately $32,000. Finally, SBI Securities Co. Ltd. lifted its position in shares of Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after buying an additional 1,027 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of several research analyst reports. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Barclays reduced their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Citigroup dropped their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Finally, Argus upgraded Kenvue to a “hold” rating in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $19.33.

Kenvue Trading Up 2.0%

NYSE KVUE opened at $18.77 on Thursday. The firm’s fifty day moving average is $17.60 and its two-hundred day moving average is $17.61. Kenvue Inc. has a one year low of $14.02 and a one year high of $22.87. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The firm has a market cap of $36.05 billion, a PE ratio of 22.09, a P/E/G ratio of 1.40 and a beta of 0.54.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. During the same period in the prior year, the business earned $0.24 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. Analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is 97.65%.

Insiders Place Their Bets

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.59% of the stock is currently owned by company insiders.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.